NYU Dentistry, LLS to provide dental care for veterans with blood cancer

NYU study details how cancer cells evade chemotherapy

Laboratory experiments with cancer cells reveal two ways in which tumors evade chemotherapy drugs designed to starve and kill them, a new study in Nature Metabolism shows.

December 06, 2024

Vol.50 No.45

In Brief

NYU pain research center receives $4.5M NIH grant to study chemotherapy-related pain

NIH has awarded a five-year, $4.63 million grant to NYU College of Dentistry researchers to study chemotherapy-induced painful peripheral neuropathy, or CIPPN.

October 11, 2024

Vol.50 No.38

In Brief

Jonathan Gerber named chief clinical officer of NYU Langone Health’s Perlmutter Cancer Center

Jonathan M. Gerber was named chief clinical officer of NYU Langone Health’s Perlmutter Cancer Center.

July 26, 2024

Vol.50 No.30

Clinical Roundup

Cell donor’s socioeconomic status shapes cancer treatment outcomes

The socioeconomic status of cell donors affects the health outcomes of blood cancer patients who underwent hematopoietic cell transplantation, according to a new study led by researchers at the University of Minnesota Medical School.

July 19, 2024

Vol.50 No.29

Clinical Roundup

AI tool helps to diagnose and predict severity of lung cancers

A computer program based on data from nearly a half-million tissue images and powered by artificial intelligence can accurately diagnose cases of adenocarcinoma, the most common form of lung cancer, a study published June 11 in Nature Communications shows.

June 14, 2024

Vol.50 No.24

Drugs & Targets

Estonia to develop personalized CAR T-cell therapy for blood cancer patients

The Tartu University Hospital, North Estonia Medical Centre, and Icosagen have joined forces to develop and introduce an innovative personalized cell therapy for patients in Estonia.

May 31, 2024

Vol.50 No.22

NYU Dentistry, LLS to provide dental care for veterans with blood cancer

YOU MAY BE INTERESTED IN

NYU study details how cancer cells evade chemotherapy

NYU pain research center receives $4.5M NIH grant to study chemotherapy-related pain

Jonathan Gerber named chief clinical officer of NYU Langone Health’s Perlmutter Cancer Center

Cell donor’s socioeconomic status shapes cancer treatment outcomes

AI tool helps to diagnose and predict severity of lung cancers

Estonia to develop personalized CAR T-cell therapy for blood cancer patients

Renew today!

Subscriber content

Never miss an issue!

Login